Skip to content

Net margin at other companies

ResMed logo
ResMedRMD
27.4%+1.3pp
LivaNova logo
LivaNovaLIVN
-16.1%-18.0pp
Globus Medical logo
Globus MedicalGMED
18.9%+11.5pp
Stryker logo
StrykerSYK
13.2%+0.9pp
ITG
Integer HoldingsITGR
7.6%+3.2pp
Medtronic logo
MedtronicMDT
13.2%-0.7pp

Other financials

Income statement

See full
Revenue$204.6M+1.6%
Gross profit$176.9M+3.7%
Operating income-$1.1M+24.7%
Net income-$11.3M-477%
EPS (diluted)-$0.39-490%

Balance sheet

See full
Cash & equivalents$98.9M+83.6%
Total debt$29.6M-11.8%
Total equity$792.3M+24.6%
Total assets$911.4M+24.7%

Cash flow

See full
Operating cash flow$12.8M+292%
CapEx$9.7M+15.7%
Free cash flow$3.1M+121%

Valuation

See full
Market cap$1.24B-67.8%
Enterprise value$1.18B-69.4%
P/E9.5×-48.6×
P/S1.4×-3.2×

Profitability

See full
Gross margin85.8%+1.1pp
Operating margin5.6%-0.3pp
FCF margin10.6%+1.2pp

Returns & leverage

See full
Return on equity18.4%+7.5pp
Debt / equity0.0×
Current ratio6.3×-2.7×

Where this comes from

Calculated from Inspire Medical Systems’s reported figures.

Based on trailing twelve months.

The official record: Inspire Medical Systems’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Inspire Medical Systems's net margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Inspire Medical Systems's net margin?
Inspire Medical Systems (INSP) reported net margin of 14.3% in Q1 2026.
How has Inspire Medical Systems's net margin changed year-over-year?
Inspire Medical Systems's net margin increased by 81.0% year-over-year, from 7.9% to 14.3%.
What is the long-term trend for Inspire Medical Systems's net margin?
Over 4 years (2020 to 2025), Inspire Medical Systems's net margin has grown at a -24.7% compound annual growth rate (CAGR), from -49.6% to 15.9%.
What does net margin mean?
Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.